|
54920
|
|
(R)-3-Hydroxybutyric acid ≥98.0% (T)
|
|
|
|
|
|
O6754
|
|
1-Oleoyl-2-acetyl-sn-glycerol ≥97% (TLC), oil
|
Often used as an activator of calcium-dependent protein kinase C (PKC).
|
|
|
|
|
C6146
|
|
2-Butenoyl coenzyme A lithium salt ≥90% (HPLC)
|
|
|
|
|
|
M2787
|
|
2-Oleoylglycerol ≥94% (TLC)
|
2-Monoolein (2-Oleoylglycerol) is used as a GPR119 agonist than regulates GLP-1 release. 2-Monoolein may be used to differentiate and study the kinetics of monoacylglycerol lipase(s).
|
|
|
|
|
D3385
|
|
3′-Dephosphocoenzyme A ≥90% (HPLC)
|
|
|
|
|
|
H6132
|
|
DL-3-Hydroxy-3-methylglutaryl coenzyme A sodium salt hydrate ≥90% (HPLC)
|
DL-3-Hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) is a substrate used to study the specificity and kinetics of the enzyme 3-hydroxyl-3-methyl-glutaryl coenzyme A (HMG-CoA) reductase. HMG-CoA is the key intermediate in the biosynthsis of terpenes, cholesterol, and ketone bodies. Its metabolism is the target of statin drugs used to control cholesterol levels.
|
|
|
|
|
H0261
|
|
DL-β-Hydroxybutyryl coenzyme A lithium salt ≥90%
|
3-Hydroxybutyryl coenzyme A (HBCoA) is converted to bacterial polyhydroxyalkanoates (PHB) by polyhydroxybutyrate (PHB) synthases. 3-Hydroxybutyryl coenzyme A is a substrate used to measure the specificity and kinetics of β-hydroxyacyl CoA dehydrogenase.
|
|
|
|
|
A1625
|
|
Acetoacetyl coenzyme A sodium salt hydrate cofactor for acyl transfer
|
|
|
|
|
|
A2181
|
|
Acetyl coenzyme A lithium salt ≥93% (HPLC)
|
Acetyl-CoA is an essential cofactor and carrier of acyl groups in enzymatic acetyl transfer reactions. It is formed either by the oxidative decarboxylation of pyruvate in mitochondria, by the oxidation of long-chain fatty acids, or by the oxidative degradation of certain amino acids. Acetyl-CoA is the starting compound for the citric acid cycle (Kreb′s cycle). It is also a key precursor in lipid biosynthesis, and the source of all fatty acid carbons. Acetyl-CoA positively regulates the activity pyruvate carboxylase. It is a precursor of the neurotransmitter acetylcholine. Histone acetylases (HAT) use Acetyl-CoA as the donor for the acetyl group use in the post-translational acetylation reactions of histone and non-histone proteins.
|
|
|
|
|
A2056
|
|
Acetyl coenzyme A sodium salt ≥93% (HPLC), powder
|
Acetyl-CoA is an essential cofactor and carrier of acyl groups in enzymatic acetyl transfer reactions. It is formed either by the oxidative decarboxylation of pyruvate in mitochondria, by the oxidation of long-chain fatty acids, or by the oxidative degradation of certain amino acids. Acetyl-CoA is the starting compound for the citric acid cycle (Kreb′s cycle). It is also a key precursor in lipid biosynthesis, and the source of all fatty acid carbons. Acetyl-CoA positively regulates the activity pyruvate carboxylase. It is a precursor of the neurotransmitter acetylcholine. Histone acetylases (HAT) use Acetyl-CoA as the donor for the acetyl group use in the post-translational acetylation reactions of histone and non-histone proteins.
|
|
|
|
|
10930
|
|
Arachidic acid synthetic, ≥99.0% (GC)
|
|
|
|
|
|
10931
|
|
Arachidonic acid >95.0% (GC)
|
Arachidonic acid (AA) is an unsaturated ω6 fatty acid constituent of the phospholipids of cell membranes. Phospholipase A2 releases AA from the membrane phospholipids in response to inflammation. AA is subsequently metabolized to prostaglandins and thromboxanes by at least two cyclooxygenase (COX) isoforms, to leukotrienes and lipoxins by lipoxygenases, and to epoxyeicosatrienoic acids via cytochrome p450-catalyzed metabolism. AA and its metabolites play important roles in a variety of biological processes, including signal transduction, smooth muscle contraction, chemotaxis, cell proliferation and differentiation, and apoptosis. AA has been demonstrated to bind to the a subunit of G protein and inhibit the activity of Ras GTPase-activating proteins (GAPs). Cellular uptake of AA is energy dependent and involves protein-facilitated transport across the plasma membrane. Arachidonic acid stimulates adhesion of MDA-MB-435 human metastatic cancer cells to extracellular matrix molecules (collagen IV and vitronectin) .
|
|
|
|
|
A5837
|
|
Arachidonoyl coenzyme A lithium salt ≥85%
|
|
|
|
|
|
A0580
|
|
Arachidonylethanolamide ~98% (TLC), oil
|
An arachidonic acid derivative that is an endogenous ligand for the CB cannabinoid receptor and for the VR1 vanilloid receptor. Inhibits calcium currents in neuroblastomas and neurons. Activates the MAP kinase signaling pathway. Inhibits proliferation and induces apoptosis of lymphocytes and human breast cancer cells.
|
|
|
|
|
216941
|
|
Behenic acid 99%
|
|
|
|
|
|
B1508
|
|
Butyryl coenzyme A lithium salt hydrate ≥90%
|
Butyryl CoA is a substrate for Butyryl CoA Dehydrogenase. Butyryl CoA is involved in both lipid and butanoate metabolism.
|
|
|
|
|
C4282
|
|
Coenzyme A hydrate ≥85% (UV, HPLC)
|
Coenzyme A (CoA) is an essential metabolic cofactor synthesized from cysteine, pantothenate, and ATP. CoA plays important roles in many metabolic pathways, including the tricarboxylic acid cycle, and the synthesis and oxidation of fatty acids. One of the main functions of CoA is the carrying and transfer of acyl groups. Acylated deriviates, for example acetyl-CoA, are critical intermediates in many metabolic reactions. CoA levels can be altered during starvation, and in conditions such as cancer, diabetes, and alcoholism.
|
|
|
|
|
C3144
|
|
Coenzyme A sodium salt hydrate cofactor for acyl transfer
|
|
|
|
|
|
C3019
|
|
Coenzyme A trilithium salt ≥93%
|
|
|
|
|
|
C2643
|
|
Coenzyme A, oxidized lithium salt ≥85%
|
|
|
|
|
|
28007
|
|
Crotonoyl coenzyme A trilithium salt ~90% (HPLC)
|
|
|
|
|
|
D5269
|
|
Decanoyl coenzyme A monohydrate ≥90%
|
|
|
|
|
|
45090
|
|
Elaidic acid ≥97.0% (GC)
|
|
|
|
|
|
E4637
|
|
Elaidic acid ≥99.0% (GC)
|
|
|
|
|
|
E3385
|
|
Erucic acid ≥99% (capillary GC)
|
|
|
|
|
|
G9510
|
|
Glutaryl coenzyme A lithium salt ≥90%
|
|
|
|
|
|
H2012
|
|
Hexanoyl coenzyme A trilithium salt hydrate ≥85%
|
Coenzyme A functions as an acyl group carrier, acetyl-CoA. Hexanoyl CoA is involved in fatty acid oxidation, lipid biosynthesis, and ceramide formation. Ghrelin O-acyltransferase (GOAT) has a preference for n-hexanoyl-CoA over n-octanoyl-CoA as an acyl donor. Hexanoyl CoA is also used as a starter unit for polyketide biosynthesis.
|
|
|
|
|
I0383
|
|
Isobutyryl coenzyme A lithium salt ≥85%
|
Coenzyme A functions as an acyl group carrier, acetyl-CoA. Isobutyryl coenzyme A (IB-CoA), a short-chain branched acyl-CoA, provides the starter unit for biosynthesis of myxalamid B. Isobutyryl coenzyme A is used as a substrate to study the specificity and kinetics of isobutyryl-coenzyme A (CoA) mutase (EC 5.4.99.13).
|
|
|
|
|
I9381
|
|
Isovaleryl coenzyme A lithium salt hydrate ≥90%
|
|
|
|
|
|
L2659
|
|
Lauroyl coenzyme A lithium salt ≥90% (HPLC)
|
Coenzyme A functions as an acyl group carrier, acetyl-CoA. Dodecanoyl-Coenzyme A (C12-CoA), a long-chain (C-12) saturated fatty acyl-CoA, is used as an intermediate in lipid metabolism and is involved in lipid biosynthesis and fatty acid transport.. Lauroyl CoA is a substrate for FAM34A proteins and a product of firefly luciferase.
|
|
|
|
|
L6641
|
|
Lignoceric acid ≥99% (capillary GC)
|
|
|
|
|
|
L1376
|
|
Linoleic acid ≥99%
|
Linoleic acid increases cell proliferation and gene expression of PPARα and its target genes such as acyl-CoA oxidase in primary duck hepatocytes 1. Linoleic acid is an n-6 polyunsaturated essential fatty acid (PUFA) used as a precursor of arachidonic acid (AA) and various prostaglandins. Linoleic acid may be used to improve the delivery and efficacy of anticancer drugs and in cancer protection.
|
|
|
|
|
L2376
|
|
Linolenic acid ≥99%
|
An ω-3 fatty acid that serves as a precursor to eicosapentaenoic acid (EPA) but not docosahexaenoic acid. Conversion is greater in women than men, and conversely, β-oxidation metabolism is greater in men than women.1
|
|
|
|
|
62170
|
|
Linolenic acid ~70% (GC)
|
An ω-3 fatty acid that serves as a precursor to eicosapentaenoic acid (EPA) but not docosahexaenoic acid. Conversion is greater in women than men, and conversely, β-oxidation metabolism is greater in men than women.1
|
|
|
|
|
L9754
|
|
Linoleoyl coenzyme A lithium salt ≥85%
|
Coenzyme A functions as an acyl group carrier, acetyl-CoA. Linoleoyl coenzyme A is a substrate used to study the specificity and kinetics of mitochondrial linoleoyl-coenzyme monolysocardiolipin acyltransferase-1 (MLCL AT-1) and acyl-CoA: lysophosphatidylcholine acyltransferase (LPCAT).
|
|
|
|
|
M4263
|
|
Malonyl coenzyme A lithium salt ≥90% (HPLC)
|
Coenzyme A functions as an acyl group carrier, acetyl-CoA. Malonyl Coenzyme A is a coenzyme A derivative that is utilized in fatty acid and polyketide synthesis and in the transport of α-ketoglutarate across the mitochondrial membrane. Malonyl CoA is formed by the Acetyl CoA Carboxylase-mediated carboxylation of acetyl CoA. Malonyl-CoA is exclusively used as the extender unit in the synthesis of bacterial aromatic polyketides.
|
|
|
|
|
63410
|
|
Malonyl coenzyme A tetralithium salt ≥90% (HPLC)
|
Malonyl Coenzyme A is a Coenzyme A derivative that is utilized in fatty acid and polyketide synthesis and in the transport of α-ketoglutarate across the mitochondrial membrane. Malonyl CoA is formed by the Acetyl CoA Carboxylase-mediated carboxylation of acetyl CoA.
|
|
|
|
|
M1762
|
|
Methylmalonyl coenzyme A tetralithium salt hydrate ≥90% (HPLC)
|
|
|
|
|
|
M4414
|
|
Myristoyl coenzyme A lithium salt ≥80.0%
|
|
|
|
|
|
N1514
|
|
Nervonic acid ≥99% (capillary GC)
|
Nervonic acid (C24:1), a component of membrane sphingolipids and phosphatidylethanolamines, may be a useful predictor of chronic kidney disease mortality and diabetes. Nervonic acid oils are being studied for pharmaceutical, nutraceutical and industrial applications. Nervonic acid is a major component of Lunaria oil.
|
|
|
|
|
O6877
|
|
Octanoyl coenzyme A lithium salt hydrate ≥95 (HPLC)
|
Medium-chain fatty acid covalently linked to coenzyme A.
|
|
|
|
|
O1012
|
|
Oleoyl coenzyme A lithium salt ≥90% (HPLC)
|
|
|
|
|
|
P6775
|
|
Palmitoleoyl coenzyme A lithium salt ~90%
|
|
|
|
|
|
P9716
|
|
Palmitoyl coenzyme A lithium salt ≥90%
|
Long chain fatty acid (C16) covalently linked to Coenzyme A. Covalent attachment of palmitate is a common occurrence on a wide variety of viral and cellular proteins and plays a role in promoting membrane binding. Palmitoylation may also be a general mechanism for prolonging or potentiating G-protein signaling.
|
|
|
|
|
S3381
|
|
Sodium stearate ≥99%
|
|
|
|
|
|
S4751
|
|
Stearic acid Grade I, ≥98.5% (capillary GC)
|
|
|
|
|
|
S0802
|
|
Stearoyl coenzyme A lithium salt ≥90%
|
Stearoyl CoA is a saturated fatty acid metabolite involved in polyunsaturated fatty acid synthesis and the PPAR signaling pathway.
|
|
|
|
|
S1129
|
|
Succinyl coenzyme A sodium salt ≥85%
|
Succinyl CoA is an intermediate in the citric acid cycle. It is formed by α-ketoglutarate dehydrogenase by the decarboxylation of α-ketoglutarate. Succinyl CoA is also formed from propionyl CoA during the β-oxidation of odd-chain fatty acids. Succinyl CoA serves as a precursor in heme synthesis. It is also required for the oxidation of ketone bodies.
|
|
|
|
|
D1797
|
|
all-cis-7,10,13,16,19-Docosapentaenoic acid synthetic, ≥97%
|
|
|
|
|
|
M3013
|
|
β-Methylcrotonyl coenzyme A lithium salt ≥90%
|
|
|
|
|
|
E7752
|
|
cis-11,14-Eicosadienoic acid ethyl ester ≥98% (capillary GC), liquid
|
|
|
|
|
|
E7877
|
|
cis-11,14-Eicosadienoic acid methyl ester ≥98% (capillary GC), liquid
|
|
|
|
|
|
E3127
|
|
cis-11,14-Eicosadienoic acid ≥98%, liquid
|
|
|
|
|
|
E3635
|
|
cis-11-Eicosenoic acid ≥99% (capillary GC)
|
|
|
|
|
|
D4034
|
|
cis-13,16-Docosadienoic acid methyl ester ≥98%
|
|
|
|
|
|
E3512
|
|
cis-13-Eicosenoic acid methyl ester ~99% (capillary GC), liquid
|
|
|
|
|
|
E3387
|
|
cis-13-Eicosenoic acid ~99% (capillary GC)
|
|
|
|
|
|
E6001
|
|
cis-11,14,17-Eicosatrienoic acid methyl ester ≥98%, liquid
|
|
|
|
|
|
D8768
|
|
cis-4,7,10,13,16,19-Docosahexaenoic acid sodium salt ≥95%, waxy solid
|
|
|
|
|
|
D2534
|
|
cis-4,7,10,13,16,19-Docosahexaenoic acid ≥98%
|
Docosahexaenoic acid, DHA, is an omega-3 polyunsaturated fatty acid with 22 carbons and six double bonds, the first double bond occuring at position three from the methyl terminus (22:6 n-3). DHA is a component of lipid membranes and the myelin sheath. DHA also serves as a precursor for signaling molecules such as prostaglandins and eicosanoids.
|
|
|
|
|
E6627
|
|
cis-5,8,11,14,17-Eicosapentaenoic acid sodium salt ≥99% (capillary GC)
|
5-Lipoxygenase inhibitor; reduces thromboxane A2 production.
|
|
|
|
|
E2011
|
|
cis-5,8,11,14,17-Eicosapentaenoic acid ≥99%
|
5-Lipoxygenase inhibitor; reduces thromboxane A2 production.
|
|
|
|
|
E6013
|
|
cis-5,8,11-Eicosatrienoic acid methyl ester ~10 mg/mL in methanol, ≥90%
|
|
|
|
|
|
E5888
|
|
cis-5,8,11-Eicosatrienoic acid ~10 mg/mL in ethanol, ≥90%
|
|
|
|
|
|
E3511
|
|
cis-8,11,14-Eicosatrienoic acid methyl ester ≥99%
|
|
|
|
|
|
E4504
|
|
cis-8,11,14-Eicosatrienoic acid ≥99%
|
|
|
|
|
|
L2378
|
|
γ-Linolenic acid ≥99%, liquid
|
γ-Linolenic acid , a polyunsaturated fatty acid, exerts anti-inflammatory effect by decreasing both interleukin (IL) 6 and IL-8 production in the human enterocyte-like cell line Caco-2 and humandendritic cells in vitro 1. Gamma-linolenate (C18:6,9,12) differs from α-linolenate (C18:9,12,15) in the positions of the double bonds. Gamma-linolenate may be used in nutritional studies regarding weight regain and as a possible tumor suppression agent. Gamma-linolenate, a polyunsaturated fattly acid (PUFA), is used in studies on the mechanisms and prevention of oxidation/peroxidation of unsaturated fatty acids.
|
|
|
|
|
H1385
|
|
n-Heptadecanoyl coenzyme A lithium salt ≥90%
|
Coenzyme A functions as an acyl group carrier, acetyl-CoA. Heptadecanoyl Coenzyme A (C17-CoA), a long-chain (C-17) saturated fatty acyl-CoA, is used as an intermediate in lipid metabolism. It is a substrate of acyl-CoA dehydrogenase (EC 1.3.99.3) within the mitochondria and of carnitine O-palmitoyltransferase (EC 2.3.1.21) within the cytoplasm. Heptadecanoyl Coenzyme A is an inhibitor of general acyl-coenzyme A dehydrogenase (EC 1.3.99.3).
|
|
|
|
|
P5397
|
|
n-Propionyl coenzyme A lithium salt ≥85%
|
Propionyl coenzyme A (CoA) is the coenzyme A derivative of propionic acid. Propionyl CoA is formed during the β-oxidation of odd-chain fatty acids. Propionyl CoA is also formed during the metabolism of isoleucine and valine.
|
|
|
|